Dieulafoy lesions of the GI tract: Localization and therapeutic outcomes

Luis F. Lara, Jayaprakash Sreenarasimhaiah, Shou Jiang Tang, Bianca B. Afonso, Don C. Rockey

Research output: Contribution to journalArticle

30 Citations (Scopus)

Abstract

Objectives: Dieulafoy lesions are a rare cause of gastrointestinal hemorrhage with a striking presentation because of rapid blood loss. Endoscopic therapy is usually successful at achieving primary hemostasis, but the best mode of endoscopic intervention is not clear, and outcomes relating to variables such as gender, medication, alcohol, and smoking are not known. We reviewed the clinical experience with Dieulafoy lesions at our institution, focusing on clinico-epidemiological features, management practices, and also survival. Methods: A retrospective and prospective cohort of patients with Dieulafoy lesions who underwent endoscopy from January 2004 through April 2009 were studied and detailed clinical data were abstracted and collected. Results: We identified 63 patients with a Dieulafoy lesion. The majority were male with an average age 58 years. Hematemesis and melena were the most common presenting symptoms. Almost half the patients were on anticoagulation medication. Most of the Dieulafoy lesions occurred in the upper GI tract, and mostly in the stomach. Single-modality endoscopic therapy was used as frequently as combination therapy, and both were effective, as primary hemostasis was achieved in 92% of cases. There were 11 deaths overall; death due to Dieulafoy lesion exsanguination was attributed to three patients. Conclusions: Dieulafoy lesions occurred in younger patients than previously reported, and were more frequently diagnosed in males. Most DL lesions occurred in the upper GI tract. Primary hemostasis with endoscopic therapy was highly successful. Overall mortality was 17%, and associated with co-morbidities, and not with medical history, gender, age, or medication.

Original languageEnglish (US)
Pages (from-to)3436-3441
Number of pages6
JournalDigestive Diseases and Sciences
Volume55
Issue number12
DOIs
StatePublished - Dec 2010

Fingerprint

Gastrointestinal Tract
Upper Gastrointestinal Tract
Hemostasis
Endoscopic Hemostasis
Exsanguination
Melena
Therapeutics
Hematemesis
Gastrointestinal Hemorrhage
Practice Management
Endoscopy
Stomach
Smoking
Alcohols
Morbidity
Survival
Mortality

Keywords

  • Combination therapy
  • Dieulafoy lesion
  • Endoscopic therapy
  • Gastrointestinal bleeding
  • Hemoclips
  • Monotherapy
  • Mortality
  • Primary hemostasis
  • Secondary hemostasis

ASJC Scopus subject areas

  • Gastroenterology
  • Physiology

Cite this

Dieulafoy lesions of the GI tract : Localization and therapeutic outcomes. / Lara, Luis F.; Sreenarasimhaiah, Jayaprakash; Tang, Shou Jiang; Afonso, Bianca B.; Rockey, Don C.

In: Digestive Diseases and Sciences, Vol. 55, No. 12, 12.2010, p. 3436-3441.

Research output: Contribution to journalArticle

Lara, Luis F. ; Sreenarasimhaiah, Jayaprakash ; Tang, Shou Jiang ; Afonso, Bianca B. ; Rockey, Don C. / Dieulafoy lesions of the GI tract : Localization and therapeutic outcomes. In: Digestive Diseases and Sciences. 2010 ; Vol. 55, No. 12. pp. 3436-3441.
@article{570ff3af1249441b82b591132c9a6562,
title = "Dieulafoy lesions of the GI tract: Localization and therapeutic outcomes",
abstract = "Objectives: Dieulafoy lesions are a rare cause of gastrointestinal hemorrhage with a striking presentation because of rapid blood loss. Endoscopic therapy is usually successful at achieving primary hemostasis, but the best mode of endoscopic intervention is not clear, and outcomes relating to variables such as gender, medication, alcohol, and smoking are not known. We reviewed the clinical experience with Dieulafoy lesions at our institution, focusing on clinico-epidemiological features, management practices, and also survival. Methods: A retrospective and prospective cohort of patients with Dieulafoy lesions who underwent endoscopy from January 2004 through April 2009 were studied and detailed clinical data were abstracted and collected. Results: We identified 63 patients with a Dieulafoy lesion. The majority were male with an average age 58 years. Hematemesis and melena were the most common presenting symptoms. Almost half the patients were on anticoagulation medication. Most of the Dieulafoy lesions occurred in the upper GI tract, and mostly in the stomach. Single-modality endoscopic therapy was used as frequently as combination therapy, and both were effective, as primary hemostasis was achieved in 92{\%} of cases. There were 11 deaths overall; death due to Dieulafoy lesion exsanguination was attributed to three patients. Conclusions: Dieulafoy lesions occurred in younger patients than previously reported, and were more frequently diagnosed in males. Most DL lesions occurred in the upper GI tract. Primary hemostasis with endoscopic therapy was highly successful. Overall mortality was 17{\%}, and associated with co-morbidities, and not with medical history, gender, age, or medication.",
keywords = "Combination therapy, Dieulafoy lesion, Endoscopic therapy, Gastrointestinal bleeding, Hemoclips, Monotherapy, Mortality, Primary hemostasis, Secondary hemostasis",
author = "Lara, {Luis F.} and Jayaprakash Sreenarasimhaiah and Tang, {Shou Jiang} and Afonso, {Bianca B.} and Rockey, {Don C.}",
year = "2010",
month = "12",
doi = "10.1007/s10620-010-1385-0",
language = "English (US)",
volume = "55",
pages = "3436--3441",
journal = "Digestive Diseases and Sciences",
issn = "0163-2116",
publisher = "Springer New York",
number = "12",

}

TY - JOUR

T1 - Dieulafoy lesions of the GI tract

T2 - Localization and therapeutic outcomes

AU - Lara, Luis F.

AU - Sreenarasimhaiah, Jayaprakash

AU - Tang, Shou Jiang

AU - Afonso, Bianca B.

AU - Rockey, Don C.

PY - 2010/12

Y1 - 2010/12

N2 - Objectives: Dieulafoy lesions are a rare cause of gastrointestinal hemorrhage with a striking presentation because of rapid blood loss. Endoscopic therapy is usually successful at achieving primary hemostasis, but the best mode of endoscopic intervention is not clear, and outcomes relating to variables such as gender, medication, alcohol, and smoking are not known. We reviewed the clinical experience with Dieulafoy lesions at our institution, focusing on clinico-epidemiological features, management practices, and also survival. Methods: A retrospective and prospective cohort of patients with Dieulafoy lesions who underwent endoscopy from January 2004 through April 2009 were studied and detailed clinical data were abstracted and collected. Results: We identified 63 patients with a Dieulafoy lesion. The majority were male with an average age 58 years. Hematemesis and melena were the most common presenting symptoms. Almost half the patients were on anticoagulation medication. Most of the Dieulafoy lesions occurred in the upper GI tract, and mostly in the stomach. Single-modality endoscopic therapy was used as frequently as combination therapy, and both were effective, as primary hemostasis was achieved in 92% of cases. There were 11 deaths overall; death due to Dieulafoy lesion exsanguination was attributed to three patients. Conclusions: Dieulafoy lesions occurred in younger patients than previously reported, and were more frequently diagnosed in males. Most DL lesions occurred in the upper GI tract. Primary hemostasis with endoscopic therapy was highly successful. Overall mortality was 17%, and associated with co-morbidities, and not with medical history, gender, age, or medication.

AB - Objectives: Dieulafoy lesions are a rare cause of gastrointestinal hemorrhage with a striking presentation because of rapid blood loss. Endoscopic therapy is usually successful at achieving primary hemostasis, but the best mode of endoscopic intervention is not clear, and outcomes relating to variables such as gender, medication, alcohol, and smoking are not known. We reviewed the clinical experience with Dieulafoy lesions at our institution, focusing on clinico-epidemiological features, management practices, and also survival. Methods: A retrospective and prospective cohort of patients with Dieulafoy lesions who underwent endoscopy from January 2004 through April 2009 were studied and detailed clinical data were abstracted and collected. Results: We identified 63 patients with a Dieulafoy lesion. The majority were male with an average age 58 years. Hematemesis and melena were the most common presenting symptoms. Almost half the patients were on anticoagulation medication. Most of the Dieulafoy lesions occurred in the upper GI tract, and mostly in the stomach. Single-modality endoscopic therapy was used as frequently as combination therapy, and both were effective, as primary hemostasis was achieved in 92% of cases. There were 11 deaths overall; death due to Dieulafoy lesion exsanguination was attributed to three patients. Conclusions: Dieulafoy lesions occurred in younger patients than previously reported, and were more frequently diagnosed in males. Most DL lesions occurred in the upper GI tract. Primary hemostasis with endoscopic therapy was highly successful. Overall mortality was 17%, and associated with co-morbidities, and not with medical history, gender, age, or medication.

KW - Combination therapy

KW - Dieulafoy lesion

KW - Endoscopic therapy

KW - Gastrointestinal bleeding

KW - Hemoclips

KW - Monotherapy

KW - Mortality

KW - Primary hemostasis

KW - Secondary hemostasis

UR - http://www.scopus.com/inward/record.url?scp=78649321926&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=78649321926&partnerID=8YFLogxK

U2 - 10.1007/s10620-010-1385-0

DO - 10.1007/s10620-010-1385-0

M3 - Article

C2 - 20848205

AN - SCOPUS:78649321926

VL - 55

SP - 3436

EP - 3441

JO - Digestive Diseases and Sciences

JF - Digestive Diseases and Sciences

SN - 0163-2116

IS - 12

ER -